SCHEMBL4126889

SCHEMBL4126889

CCCOc1ccc2c(C)noc2c1CO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 18/20 0.41
PPARA Q07869 17/20 0.41
PPARG P37231 17/20 0.41
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4126821 0.76 ACHE (0.40) PPARDPPARAPPARG
SCHEMBL13597386 0.75 PPARD (0.44) PPARDPPARAPPARGNR1H2NR1H3
SCHEMBL13596407 0.74 CSF1R (0.41) PPARDPPARAPPARG
SCHEMBL4126911 0.70
SCHEMBL4126887 0.69 NR1H2 (0.33) PPARDPPARAPPARGNR1H2NR1H3
SCHEMBL706843 0.68 SMYD2 (0.40)
SCHEMBL20983501 0.66 CYP3A4 (0.33)
SCHEMBL4113718 0.65 EDNRA (0.37)
SCHEMBL4112472 0.64
SCHEMBL13596012 0.64 ALDH1A1 (0.39) PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 PPARD 924/4885PPARA 911/4885PPARG 498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.